Lurbinectedin in small cell lung cancer: real-world experience of a multicentre national early access programme.

Marliese AlexanderJennifer RogersSagun ParakhPaul MitchellTimothy D ClaySteven KaoBrett G M HughesMalinda ItchinsBenjamin Y KongNick PavlakisBenjamin J SolomonThomas John

Published in: Internal medicine journal (2024)

This real-world national experience of lurbinectedin post-platinum chemotherapy and immunotherapy for individuals with SCLC was similar to that reported in clinical trials.

Keyphrases

clinical trial
small cell lung cancer
quality improvement
study protocol
randomized controlled trial
locally advanced
cross sectional
double blind
phase ii